Standout Papers

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in mi... 2018 2026 2020 2023 260
  1. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial (2018)
    Michael C. Mithoefer, Ann T. Mithoefer et al. The Lancet Psychiatry

Immediate Impact

6 from Science/Nature 71 standout
Sub-graph 1 of 21

Citing Papers

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
2023 StandoutScience
Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study
2023 Standout
9 intermediate papers

Works of Ann T. Mithoefer being referenced

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
2012
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
2010
and 1 more

Author Peers

Author Last Decade Papers Cites
Ann T. Mithoefer 986 393 128 469 10 1.1k
Allison A. Feduccia 969 348 111 418 16 1.1k
Amy Emerson 896 341 89 389 23 1.0k
Theo Huber 775 240 286 547 8 1.2k
Patrick Vizeli 1000 192 68 617 32 1.1k
Ben Sessa 827 184 139 440 29 984
Alicia Danforth 1149 172 54 550 9 1.2k
R. R. Griffiths 1231 150 58 533 5 1.4k
Cédric M. Hysek 857 391 130 552 20 1.2k
Matthew J. Baggott 567 356 155 454 31 1.3k
Rainer Kraehenmann 1150 128 194 735 26 1.4k

All Works

Loading papers...

Rankless by CCL
2026